体外式膜型人工肺（ECMO）の世界市場 2024-2028

体外式膜型人工肺市場は2023-2028年に1億4,504万米ドル、予測期間中のCAGRは5.92％で成長すると予測されています。

当レポートでは、体外式膜型人工肺市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、呼吸不全や心不全の罹患率の増加、新製品の発売数の増加、臓器移植手術件数の増加によって牽引されています。

本調査では、ECMO装置の技術的進歩が今後数年間の体外式膜型人工肺市場成長を牽引する主要因の1つであるとしています。また、ECMOマシンの使用による呼吸不全患者の良好な転帰や、小児医療・治療におけるECMOマシンの採用増加も、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 体外式膜型人工肺の世界市場 2018-2022
• モダリティセグメント分析 2018-2022
• 製品セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 モダリティ別市場セグメンテーション

• 市場セグメント
• 比較：モダリティ別
• 静脈と動脈と静脈：市場規模と予測 2023-2028
• 静脈動脈：市場規模と予測 2023-2028
• 市場機会：モダリティ別

第7章 製品別の市場セグメンテーション

• 市場セグメント
• 比較：製品別
• ECMO装置：市場規模と予測 2023-2028
• ソフトウェア：市場規模と予測 2023-2028
• 市場機会：製品別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• Braile Biomedica
• Chalice Medical Ltd.
• Eurosets Srl
• Fresenius SE and Co. KGaA
• Getinge AB
• LivaNova PLC
• MC3 Cardiopulmonary
• Medtronic
• MicroPort Scientific Corp.
• Nipro Corp.
• OriGen Biomedical Inc.
• Sechrist Industries Inc.
• Senko Medical Instrument Mfg. Co. Ltd.
• Terumo Corp.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Modality
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global extracorporeal membrane oxygenation machines market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits24: Five forces analysis - Comparison between 2023 and 2028
• Exhibits25: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits30: Chart on Market condition - Five forces 2023 and 2028
• Exhibits31: Chart on Modality - Market share 2023-2028 (%)
• Exhibits32: Data Table on Modality - Market share 2023-2028 (%)
• Exhibits33: Chart on Comparison by Modality
• Exhibits34: Data Table on Comparison by Modality
• Exhibits35: Chart on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Data Table on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Chart on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
• Exhibits38: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
• Exhibits39: Chart on Veno-arterial - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Data Table on Veno-arterial - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Chart on Veno-arterial - Year-over-year growth 2023-2028 (%)
• Exhibits42: Data Table on Veno-arterial - Year-over-year growth 2023-2028 (%)
• Exhibits43: Market opportunity by Modality ($ million)
• Exhibits44: Data Table on Market opportunity by Modality ($ million)
• Exhibits45: Chart on Product - Market share 2023-2028 (%)
• Exhibits46: Data Table on Product - Market share 2023-2028 (%)
• Exhibits47: Chart on Comparison by Product
• Exhibits48: Data Table on Comparison by Product
• Exhibits49: Chart on ECMO machines - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Data Table on ECMO machines - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Chart on ECMO machines - Year-over-year growth 2023-2028 (%)
• Exhibits52: Data Table on ECMO machines - Year-over-year growth 2023-2028 (%)
• Exhibits53: Chart on Softwares - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Data Table on Softwares - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Chart on Softwares - Year-over-year growth 2023-2028 (%)
• Exhibits56: Data Table on Softwares - Year-over-year growth 2023-2028 (%)
• Exhibits57: Market opportunity by Product ($ million)
• Exhibits58: Data Table on Market opportunity by Product ($ million)
• Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits60: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits61: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits62: Chart on Geographic comparison
• Exhibits63: Data Table on Geographic comparison
• Exhibits64: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits71: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits72: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits75: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits76: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits79: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits83: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits87: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits88: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits91: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits92: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits95: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits96: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits100: Market opportunity By Geographical Landscape ($ million)
• Exhibits101: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Impact of drivers and challenges in 2023 and 2028
• Exhibits103: Overview on Criticality of inputs and Factors of differentiation
• Exhibits104: Overview on factors of disruption
• Exhibits105: Impact of key risks on business
• Exhibits106: Vendors covered
• Exhibits107: Matrix on vendor position and classification
• Exhibits108: Abbott Laboratories - Overview
• Exhibits109: Abbott Laboratories - Business segments
• Exhibits110: Abbott Laboratories - Key offerings
• Exhibits111: Abbott Laboratories - Segment focus
• Exhibits112: Braile Biomedica - Overview
• Exhibits113: Braile Biomedica - Product / Service
• Exhibits114: Braile Biomedica - Key offerings
• Exhibits115: Chalice Medical Ltd. - Overview
• Exhibits116: Chalice Medical Ltd. - Product / Service
• Exhibits117: Chalice Medical Ltd. - Key offerings
• Exhibits118: Eurosets Srl - Overview
• Exhibits119: Eurosets Srl - Product / Service
• Exhibits120: Eurosets Srl - Key offerings
• Exhibits121: Fresenius SE and Co. KGaA - Overview
• Exhibits122: Fresenius SE and Co. KGaA - Business segments
• Exhibits123: Fresenius SE and Co. KGaA - Key news
• Exhibits124: Fresenius SE and Co. KGaA - Key offerings
• Exhibits125: Fresenius SE and Co. KGaA - Segment focus
• Exhibits126: Getinge AB - Overview
• Exhibits127: Getinge AB - Business segments
• Exhibits128: Getinge AB - Key news
• Exhibits129: Getinge AB - Key offerings
• Exhibits130: Getinge AB - Segment focus
• Exhibits131: LivaNova PLC - Overview
• Exhibits132: LivaNova PLC - Business segments
• Exhibits133: LivaNova PLC - Key news
• Exhibits134: LivaNova PLC - Key offerings
• Exhibits135: LivaNova PLC - Segment focus
• Exhibits136: MC3 Cardiopulmonary - Overview
• Exhibits137: MC3 Cardiopulmonary - Product / Service
• Exhibits138: MC3 Cardiopulmonary - Key offerings
• Exhibits139: Medtronic - Overview
• Exhibits140: Medtronic - Business segments
• Exhibits141: Medtronic - Key news
• Exhibits142: Medtronic - Key offerings
• Exhibits143: Medtronic - Segment focus
• Exhibits144: MicroPort Scientific Corp. - Overview
• Exhibits145: MicroPort Scientific Corp. - Business segments
• Exhibits146: MicroPort Scientific Corp. - Key offerings
• Exhibits147: MicroPort Scientific Corp. - Segment focus
• Exhibits148: Nipro Corp. - Overview
• Exhibits149: Nipro Corp. - Business segments
• Exhibits150: Nipro Corp. - Key offerings
• Exhibits151: Nipro Corp. - Segment focus
• Exhibits152: OriGen Biomedical Inc. - Overview
• Exhibits153: OriGen Biomedical Inc. - Product / Service
• Exhibits154: OriGen Biomedical Inc. - Key offerings
• Exhibits155: Sechrist Industries Inc. - Overview
• Exhibits156: Sechrist Industries Inc. - Product / Service
• Exhibits157: Sechrist Industries Inc. - Key offerings
• Exhibits158: Senko Medical Instrument Mfg. Co. Ltd. - Overview
• Exhibits159: Senko Medical Instrument Mfg. Co. Ltd. - Product / Service
• Exhibits160: Senko Medical Instrument Mfg. Co. Ltd. - Key offerings
• Exhibits161: Terumo Corp. - Overview
• Exhibits162: Terumo Corp. - Business segments
• Exhibits163: Terumo Corp. - Key news
• Exhibits164: Terumo Corp. - Key offerings
• Exhibits165: Terumo Corp. - Segment focus
• Exhibits166: Inclusions checklist
• Exhibits167: Exclusions checklist
• Exhibits168: Currency conversion rates for US$
• Exhibits169: Research methodology
• Exhibits170: Validation techniques employed for market sizing
• Exhibits171: Information sources
• Exhibits172: List of abbreviations

The extracorporeal membrane oxygenation machines market is forecasted to grow by USD 145.04 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of organ transplant procedures.

Technavio's extracorporeal membrane oxygenation machines market is segmented as below:

By Modality

• Veno-venous and arterio-venous
• Veno-arterial

By Product

• ECMO machines
• Softwares

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in ECMO machines as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, favorable outcomes in patients with respiratory failure due to use of ECMO machines and increasing adoption of ECMO machines in pediatric care and treatment will lead to sizable demand in the market.

The report on the extracorporeal membrane oxygenation machines market covers the following areas:

• Extracorporeal membrane oxygenation machines market sizing
• Extracorporeal membrane oxygenation machines market forecast
• Extracorporeal membrane oxygenation machines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp.. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global extracorporeal membrane oxygenation machines market 2018 - 2022
• 4.2 Modality Segment Analysis 2018 - 2022
• 4.3 Modality Segment Analysis 2018 - 2022
• 4.4 Product Segment Analysis 2018 - 2022
• 4.5 Geography Segment Analysis 2018 - 2022
• 4.6 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Modality

• 6.1 Market segments
• 6.2 Comparison by Modality
• 6.3 Veno-venous and arterio-venous - Market size and forecast 2023-2028
• 6.4 Veno-arterial - Market size and forecast 2023-2028
• 6.5 Market opportunity by Modality

7 Market Segmentation by Product

• 7.1 Market segments
• 7.2 Comparison by Product
• 7.3 ECMO machines - Market size and forecast 2023-2028
• 7.4 Softwares - Market size and forecast 2023-2028
• 7.5 Market opportunity by Product

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 UK - Market size and forecast 2023-2028
• 9.10 Canada - Market size and forecast 2023-2028
• 9.11 China - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 Braile Biomedica
• 12.5 Chalice Medical Ltd.
• 12.6 Eurosets Srl
• 12.7 Fresenius SE and Co. KGaA
• 12.8 Getinge AB
• 12.9 LivaNova PLC
• 12.10 MC3 Cardiopulmonary
• 12.11 Medtronic
• 12.12 MicroPort Scientific Corp.
• 12.13 Nipro Corp.
• 12.14 OriGen Biomedical Inc.
• 12.15 Sechrist Industries Inc.
• 12.16 Senko Medical Instrument Mfg. Co. Ltd.
• 12.17 Terumo Corp.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations